Cardio-kidney outcomes for combined versus monotherapy with finerenone or SGLT2 inhibitors in patients with CKD. Chuang MH, Wang HY, Kan WC, Chien CC, et al. Nephrol Dial Transplant 2025;40:1897-1905.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Chuang MH, Wang HY, Kan WC, Chien CC, et al. Cardio-kidney outcomes for combined versus monotherapy with finerenone or SGLT2 inhibitors in patients with CKD. Nephrol Dial Transplant 2025;40:1897-1905.
PMID: 40199739